The fine chemical sector in Europe is witnessing a notable transformation, primarily fueled by the pharmaceutical industry ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Banks are getting ready to submit final offers to Brookfield Asset Management for a debt package of about €11 billion ($11.6 ...

The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...

Novo Nordisk Chief Financial Officer Karsten Munk Knudsen talks with Bloomberg Television after the Copenhagen-based drugmaker said sales of the blockbuster weight-loss drug Wegovy leapt by about ...